CCR5 and myeloid sarcoma: In multiple sclerosis (MS), CCR5 absence is supposed to play a role in reducing the migration of lymphocytes towards lesion sites and, therefore, it might suppress the pathogenesis of the disease and limit the inflammation of brain tissue.